Program News
News and stories about members of the UNC Lineberger Cancer Genetics Research Program
-
UNC researchers unlock new way to help fight skin cancer
Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR-T therapy to better fight off melanoma.
-
UNC Lineberger continues its national leadership in breast cancer research
UNC Lineberger researchers are leading next-generation clinical breast cancer trials as part of a national project using cutting-edge technologies to track tumor changes in real time.
-
Researchers awarded $11.2M grant to close endometrial cancer survival gap
The National Cancer Institute has awarded a Cancer Health Disparities Specialized Program of Research Excellence (SPORE) in Endometrial Cancer grant to UNC Lineberger’s Victoria Bae-Jump, MD, PhD, and Hazel Nichols, PhD.
-
Ramsden receives Battle Award for groundbreaking genome stability research
Dale Ramsden, PhD, was presented with the Battle Award for his research on how cells repair DNA double-strand breaks, a critical process for maintaining genome stability and preventing cancer-causing mutations.
-
UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer
UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.
-
UNC Lineberger and UNC faculty and trainees present findings at AACR annual meeting
Nearly 30 UNC Lineberger and UNC faculty and trainees will present findings and participate during the American Association for Cancer Research annual meeting in Chicago, April 25-30.
-
Adaptive whole-genome sequencing could transform childhood leukemia diagnosis
UNC Lineberger researchers have demonstrated a faster, more cost-effective approach to analyzing the genetic makeup of pediatric acute leukemia. Determining a cancer’s genomic classification is critical to developing a more effective treatment plan tailored to a patient’s tumor.
-
International breast cancer meeting features UNC Lineberger research
More than 10,000 cancer researchers, clinicians and patient advocates from across the globe are expected to attend this year’s San Antonio Breast Cancer Symposium. The meeting will feature presentations by several UNC faculty members and trainees.
-
UNC Lineberger members recognized for highly cited research
Nine UNC Lineberger members wrote some of the most influential scientific papers in the past decade, according to an independent analysis of research publications.
-
Kim, Rose highlight advances in kidney cancer research and care in JAMA
William Kim, MD, and Tracy Rose, MD, MPH, published a review highlighting new scientific insights that have led to advances in kidney cancer treatment and increased survival rates.
-
Immune cell transformation can influence stem cell transplant success in cancer patients
Jonathan Serody, MD, Ian Davis, MD, PhD, and colleagues report ILC2s can change functions after a patient receives stem cells, thereby preventing a healthy rebuilding of the immune system.
-
Scientific symposium highlights latest developments in pancreatic cancer research
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
-
Cancer center researchers to present latest findings at international breast cancer meeting
The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.
-
Scientists piece together DNA repair pathway implicated in breast, ovarian, and prostate cancers
Researchers have learned more about an enzyme found to be overly expressed in patients with hereditary breast cancer, ovarian cancer and prostate cancer.
-
UNC Lineberger faculty named world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.